stars 1 stars 2 stars 3

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by our proprietary synthetic lethality approach to discovering and developing novel therapeutics. We use our genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Our company was founded in 2016 by field-leading academics to systematically employ synthetic lethality insights and platforms and develop new precision oncology medicines. For more information, please visit www.reparerx.com.

View Top Employees from Repare Therapeutics

Repare Therapeutics Questions

The Repare Therapeutics annual revenue was $7.8 million in 2024.

Lloyd Segal is the President and Chief Executive Officer of Repare Therapeutics.

184 people are employed at Repare Therapeutics.

Repare Therapeutics is based in Montreal, Quebec.

The NAICS codes for Repare Therapeutics are [325, 32, 541, 32541, 54, 3254].

The SIC codes for Repare Therapeutics are [283, 28].

Top Repare Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users